Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
22
OMI Quote, Financials, Valuation and Earnings
Last price:
$8.05
Seasonality move
:
7.07%
Day range:
$7.62 - $7.99
52-week range:
$6.07 - $16.98
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.06x
P/B ratio:
1.06x
Volume:
652.1K
Avg. volume:
1.4M
1-year change:
-45.05%
Market cap:
$607.5M
Revenue:
$10.7B
EPS (TTM):
-$4.75
Analysts' Opinion
-
Consensus RatingOwens & Minor has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 2 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $9.42, Owens & Minor has an estimated upside of 18.75% from its current price of $7.93.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $7.00 representing 100% downside risk from its current price of $7.93.
Fair Value
-
According to the consensus of 4 analysts, Owens & Minor has 18.75% upside to fair value with a price target of $9.42 per share.
OMI vs. S&P 500
-
Over the past 5 trading days, Owens & Minor has underperformed the S&P 500 by -8.17% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Owens & Minor does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Owens & Minor has grown year-over-year revenues for 10 quarters straight. In the most recent quarter Owens & Minor reported revenues of $2.6B.
Earnings Growth
-
Owens & Minor earnings have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Owens & Minor reported earnings per share of -$0.32.
Enterprise value:
2.5B
EV / Invested capital:
--
Price / LTM sales:
0.06x
EV / EBIT:
23.81x
EV / Revenue:
0.23x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-38.83x
Price / Operating cash flow:
9.11x
Enterprise value / EBITDA:
86.87x
Gross Profit (TTM):
$2.2B
Return On Assets:
-7.29%
Net Income Margin (TTM):
-3.41%
Return On Equity:
-48.56%
Return On Invested Capital:
-13.38%
Operating Margin:
2.32%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $10.1B | $10.4B | $10.7B | $2.6B | $2.6B | |
| Gross Profit | $2B | $2.2B | $2.2B | $535.5M | $526M | |
| Operating Income | $219.6M | $314.4M | $299.7M | $57.4M | $61M | |
| EBITDA | $363.4M | $393.9M | $28.6M | $82.6M | $60M | |
| Diluted EPS | -$0.56 | -$0.51 | -$4.75 | -$0.29 | -$0.32 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.2B | $2.6B | $2.3B | $2.2B | $2.2B | |
| Total Assets | $3.4B | $5.7B | $5.3B | $5.2B | $4.9B | |
| Current Liabilities | $1.3B | $1.7B | $1.6B | $1.9B | $2B | |
| Total Liabilities | $2.6B | $4.8B | $4.4B | $4.3B | $4.3B | |
| Total Equity | $786.3M | $947.6M | $924.4M | $894.9M | $571M | |
| Total Debt | $981.3M | $2.6B | $2.4B | $2.2B | $1.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $403.7M | $529.4M | $179.4M | -$53M | -$35.1M | |
| Cash From Investing | -$251.4M | -$104.9M | -$162.9M | -$1.9M | -$48.2M | |
| Cash From Financing | -$294.6M | -$236.5M | -$228.1M | $53.3M | $92.8M | |
| Free Cash Flow | $196.6M | $323.5M | -$64M | -$102.4M | -$99.7M | |
OMI
Sector
Market Cap
$607.5M
$34.4M
Price % of 52-Week High
46.7%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.01%
1-Year Price Total Return
-45.05%
-37.36%
Beta (5-Year)
1.397
0.614
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$8.29
200-day SMA
Sell
Level
$10.50
Bollinger Bands (100)
Buy
Level
6.81 - 8.97
Chaikin Money Flow
Sell
Level
-540K
20-day SMA
Sell
Level
$8.28
Relative Strength Index (RSI14)
Sell
Level
47.18
ADX Line
Sell
Level
34.17
Williams %R
Buy
Level
-83.9378
50-day SMA
Buy
Level
$7.66
MACD (12, 26)
Buy
Level
2.19
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Sell
Level
-2.8M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3346)
Sell
CA Score
(Annual)
Level (-1.3937)
Buy
Beneish M-Score
(Annual)
Level (-2.9278)
Buy
Momentum Score
Level (2)
Sell
Ohlson Score
Level (2.1012)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
Stock Forecast FAQ
In the current month, OMI has received 2 Buy ratings 2 Hold ratings, and 0 Sell ratings. The OMI average analyst price target in the past 3 months is $9.42.
-
Where Will Owens & Minor Stock Be In 1 Year?
According to analysts, the consensus estimate is that Owens & Minor share price will rise to $9.42 per share over the next 12 months.
-
What Do Analysts Say About Owens & Minor?
Analysts are divided on their view about Owens & Minor share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Owens & Minor is a Sell and believe this share price will drop from its current level to $7.00.
-
What Is Owens & Minor's Price Target?
The price target for Owens & Minor over the next 1-year time period is forecast to be $9.42 according to 4 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is OMI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Owens & Minor is a Leans Bullish. 2 of 4 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of OMI?
You can purchase shares of Owens & Minor via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Owens & Minor shares.
-
What Is The Owens & Minor Share Price Today?
Owens & Minor was last trading at $8.05 per share. This represents the most recent stock quote for Owens & Minor. Yesterday, Owens & Minor closed at $7.93 per share.
-
How To Buy Owens & Minor Stock Online?
In order to purchase Owens & Minor stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 1.15% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.98% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 8.75% over the past day.
